Bailard’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2M Sell
53,368
-29
-0.1% -$10.7K 0.45% 49
2026
Q1
$14.4M Sell
53,397
-6,827
-11% -$2.03M 0.33% 65
2025
Q4
$19.9M Sell
60,224
-3,685
-6% -$1.25M 0.44% 48
2025
Q3
$22.1M Sell
63,909
-10,564
-14% -$3.19M 0.48% 49
2025
Q2
$23.2M Sell
74,473
-1,402
-2% -$536K 0.54% 45
2025
Q1
$39.7M Buy
75,875
+581
+0.8% +$297K 1.03% 23
2024
Q4
$38.1M Sell
75,294
-393
-0.5% -$223K 0.97% 22
2024
Q3
$44.3M Sell
75,687
-1,186
-2% -$671K 1.15% 18
2024
Q2
$39.1M Sell
76,873
-602
-0.8% -$295K 1.08% 20
2024
Q1
$38.3M Sell
77,475
-1,186
-2% -$603K 1.06% 17
2023
Q4
$41.4M Buy
78,661
+829
+1% +$442K 1.23% 16
2023
Q3
$39.2M Buy
77,832
+2,727
+4% +$1.34M 1.3% 14
2023
Q2
$36.1M Sell
75,105
-1,415
-2% -$692K 1.26% 15
2023
Q1
$36.2M Buy
76,520
+2,254
+3% +$1.09M 1.3% 16
2022
Q4
$39.4M Buy
74,266
+128
+0.2% +$67.8K 1.5% 14
2022
Q3
$37.4M Buy
74,138
+1,014
+1% +$533K 1.55% 11
2022
Q2
$37.6M Sell
73,124
-1,908
-3% -$958K 1.48% 12
2022
Q1
$38.3M Buy
75,032
+1,476
+2% +$712K 1.29% 14
2021
Q4
$36.9M Buy
73,556
+549
+0.8% +$249K 1.18% 15
2021
Q3
$28.5M Buy
73,007
+1,144
+2% +$474K 0.97% 22
2021
Q2
$28.8M Sell
71,863
-1,031
-1% -$411K 0.99% 22
2021
Q1
$27.1M Buy
72,894
+27,141
+59% +$9.4M 1.01% 23
2020
Q4
$16M Buy
45,753
+391
+0.9% +$131K 0.73% 29
2020
Q3
$14.1M Buy
45,362
+713
+2% +$219K 0.73% 30
2020
Q2
$13.2M Buy
44,649
+1,779
+4% +$510K 0.74% 28
2020
Q1
$10.7M Sell
42,870
-506
-1% -$139K 0.76% 28
2019
Q4
$12.8M Buy
43,376
+3,667
+9% +$959K 0.72% 28
2019
Q3
$8.63M Buy
39,709
+4,675
+13% +$1.13M 0.52% 43
2019
Q2
$8.55M Sell
35,034
-250
-0.7% -$60.1K 0.52% 43
2019
Q1
$8.72M Sell
35,284
-211
-0.6% -$53.8K 0.54% 38
2018
Q4
$8.84M Sell
35,495
-88
-0.2% -$23.2K 0.6% 37
2018
Q3
$9.47M Buy
35,583
+273
+0.8% +$71K 0.55% 36
2018
Q2
$8.66M Buy
35,310
+267
+0.8% +$64.1K 0.52% 43
2018
Q1
$7.5M Buy
35,043
+677
+2% +$155K 0.48% 44
2017
Q4
$7.58M Buy
34,366
+14,238
+71% +$3.02M 0.48% 40
2017
Q3
$3.94M Buy
20,128
+2,883
+17% +$557K 0.3% 80
2017
Q2
$3.2M Hold
17,245
0.26% 99
2017
Q1
$2.83M Sell
17,245
-592
-3% -$97K 0.23% 103
2016
Q4
$2.85M Buy
17,837
+1,883
+12% +$281K 0.26% 100
2016
Q3
$2.23M Buy
15,954
+2,513
+19% +$352K 0.21% 110
2016
Q2
$1.9M Buy
13,441
+3,311
+33% +$441K 0.23% 109
2016
Q1
$1.31M Buy
+10,130
New +$1.2M 0.18% 85
2015
Q4
Sell
-10,235
Closed -$1.19M 338
2015
Q3
$1.19M Sell
10,235
-445
-4% -$53.3K 0.19% 88
2015
Q2
$1.3M Sell
10,680
-270
-2% -$31.9K 0.2% 87
2015
Q1
$1.29M Sell
10,950
-255
-2% -$28.3K 0.18% 87
2014
Q4
$1.13M Buy
11,205
+100
+0.9% +$9.48K 0.16% 91
2014
Q3
$958K Sell
11,105
-318
-3% -$26.9K 0.15% 87
2014
Q2
$934K Sell
11,423
-1,215
-10% -$95.6K 0.14% 88
2014
Q1
$1.04M Sell
12,638
-601
-5% -$45.2K 0.16% 80
2013
Q4
$997K Sell
13,239
-1,832
-12% -$132K 0.16% 85
2013
Q3
$1.08M Sell
15,071
-15,826
-51% -$1.13M 0.2% 87
2013
Q2
$2.02M Buy
+30,897
New +$1.92M 0.37% 63

Other funds holding UNH

Bailard's UNH Position: Q2 2026 in Review

Bailard reduced its UnitedHealth (UNH) stake by 0.05% in Q2 2026, selling an estimated $10.7K and leaving 53,368 shares worth $22.2M. The position accounts for 0.45% of the portfolio, ranked #49.

Bailard first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $44.3M in Q3 2024. 1,641 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Bailard held 53,368 shares of UnitedHealth worth $22.2M as of Q2 2026.
  • Bailard sold 29 UnitedHealth shares in Q2 2026, an estimated $10.7K.
  • UnitedHealth made up 0.45% of Bailard's portfolio in Q2 2026, its #49 holding.
  • Bailard first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
  • Bailard's UnitedHealth position peaked at $44.3M in Q3 2024.
  • 1,641 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.